Drugs / ASP0777
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01406145 | Jun → Nov 2011 | Alzheimer disease | Astellas Pharma Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP0777 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01406145 ↗ |
| Route | Oral | “oral tablet” NCT01406145 ↗ |